S8 Ep8: Lung Cancer in Hispanic and Latinx Patients: Risk Factors, Biomarkers, and Clinical Trial Access
In this episode of Targeted Talks, recorded for Hispanic Heritage Month, Narjust Florez, MD, of Dana-Farber Cancer Institute, explains what oncologists should know about lung cancer in Hispanic and Latinx patients, one of the fastest-growing patient populations in the United States.
Florez describes how risk factors in this population often extend beyond tobacco, including radon exposure, occupational and indoor air pollution such as cooking fumes, and a history of tuberculosis. She discusses the higher frequency of adenocarcinoma and driver alterations, including EGFR, KRAS, and ALK, in the…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.